N-domain angiotensin-converting enzyme isoform expression in tissues of Wistar and spontaneously hypertensive rats

Journal of Hypertension

Volumn 23, Issue 10, 2005, Pages 1869-1878

  Ronchi, Fernanda A ^a   Andrade, Maria C C ^a   Carmona, Adriana K ^b   Krieger, José E ^c   Casarini, Dulce E ^a,b  

^a Nephrology Division   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin I converting enzyme; Angiotensin II; Different tissues; Hypertension; N domain isoform

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; HIPPURYLHISTIDYLLEUCINE; ISOENZYME; POLYACRYLAMIDE GEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; GEL FILTRATION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE HOMOGENATE; WESTERN BLOTTING;

EID: 29244485549     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000183523.66123.95     Document Type: Article

References (39)

1. Ng KK, Vane JR. Conversion of angiotensin I to angiotensin II. Nature 1967; 216:762-766.
2. Erdos EG, Yang HY. An enzyme in microsomal fraction of kidney that inactivates bradykinin. Life Sci 1967; 6:569-574.
3. Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 1996; 97:839-844.
4. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79:1-6.
5. Defendini R, Zimmerman EA, Weare JA, Alhenc-Gelas F, Erdos EG. Angiotensin-converting enzyme in epithelial and neuroepithelial cells. Neuroendocrinology 1983; 37:32-40.
6. Takada Y, Hiwada K, Kokubu T. Isolation and characterization of angiotensin converting enzyme from human kidney. J Biochem (Tokyo) 1981; 90:1309-1319.
7. Cushman DW, Cheung HS. Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta 1971; 250:261-265.
8. Chappell MC, Diz DI, Gallagher PE. The renin-angiotensin system and the exocrine pancreas. JOP 2001; 2:33-39.
9. Lattion AL, Soubrier F, Allegrini J, Hubert C, Corvol P, Alhenc-Gelas F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett 1989; 252:99-104.
10. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension 1990; 16:363-370.
11. Deddish PA, Wang J, Michel B, Morris PW, Davidson NO, Skidgel RA, Erdos EG. Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc Natl Acad Sci USA 1994; 91:7807-7811.
12. Kokubu T, Kato I, Nishimura K, Hiwada K, Ueda E. Angiotensin I-converting enzyme in human urine. Clin Chim Acta 1978; 89:375-379.
13. Casarini DE, Plavinik FL, Zanella MT, Marson O, Krieger JE, Hirata IY, Stella RC. Angiotensin converting enzymes from human urine of mild hypertensive untreated patents resemble the N-terminal fragment of human angiotensin I-converting enzyme. Int J Biochem Cell Biol 2001; 33:75-85.
14. Casarini DE, Carmona AK, Plavnik FL, Zanella MT, Juliano L, Ribeiro AB. Calcium channel blockers as inhibitors of angiotensin I-converting enzyme. Hypertension 1995; 26:1145-1148.
15. Marques GD, Quinto BM, Plavinik FL, Krieger JE, Marson O, Casarini DE. N-domain angiotensin I-converting enzyme with 80 kDa as a possible genetic marker of hypertension. Hypertension 2003; 42:693-701.
16. Oliveira EM, Santos RA, Krieger JE. Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats. Braz J Med Biol Res 2000; 33:755-764.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
18. Friedland J, Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976; 66:416-424.
19. Leatherbarrow R. Grafit Version 4.09. Erithacus Software Ltd, Staines, UK; 1999.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
21. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 1994; 15:919-926.
22. Waeber B, Nussberger J, Juillerat L, Brunner HR. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity. J Cardiovasc Pharmacol 1989; 14(suppl 4):S53-S59.
23. Ganten D, Hermann K, Unger T, Lang RE. The tissue renin-angiotensin systems: focus on brain angiotensin, adrenal gland and arterial wall. Clin Exp Hypertens 1983; A5:1099-1118.
24. Taugner R, Hackenthal E, Helmchen U, Ganten D, Kugler P, Marin-Grez M, et al. The intrarenal renin-angiotensin-system. An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins in the kidney of mouse and rat. Klin Wochenschr 1982; 60:1218-1222.
25. Pandey KN, Maki M, Inagami T. Detection of renin mRNA in mouse testis by hybridization with renin cDNA probe. Biochem Biophys Res Commun 1984; 125:662-667.
26. Carlsson PO. The renin-angiotensin system in the endocrine pancreas. JOP 2001; 2:26-32.
27. Dostal DE, Rothblum KN, Chernin MI, Cooper GR, Baker KM. Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart. Am J Physiol 1992; 263:C838-C850.
28. Vio CP, Jeanneret VA. Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases. Kidney Int Suppl 2003; 86:S57-S63.
29. Lanzillo JJ, Stevens J, Dasarathy Y, Yotsumoto H, Fanburg BL. Angiotensin-converting enzyme from human tissues. Physicochemical, catalytic, and immunological properties. J Biol Chem 1985; 260:14938-14944.
30. Andrade M, Di Marco GS, Casarini DE. Angiotensin I-converting enzymes from mesangial cells in culture from Wistar and spontaneous hypertensive rats (SHR) [Abstract]. Hypertension 2001; 38(suppl):2.
31. Araujo MC, Melo RL, Cesari MH, Juliano MA, Juliano L, Carmona AK. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry 2000; 39:8519-8525.
32. Campbell DJ, Duncan AM, Kladis A, Harrap SB. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension 1995; 25:928-934.
33. De Silva PE, Husain A, Smeby RR, Khairallah PA. Measurement of immunoreactive angiotensin peptides in rat tissues: some pitfalls in angiotensin II analysis. Anal Biochem 1988; 174:80-87.
34. Matsushima Y, Kawamura M, Akabane S, Imanishi M, Kuramochi M, Ito K, Omae T. Increases in renal angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rats. J Hypertens 1988; 6:791-796.
35. Reams G, Villarreal D, Bauer JH. Intrarenal metabolism of angiotensin II. Am J Physiol 1990; 258:F1510-F1515.
36. Mendelsohn FA. A method for measurement of angiotensin II in tissues and its application to rat kidney. Clin Sci Mol Med 1976; 51:111-125.
37. Phillips MI, Stenstrom B. Angiotensin II in rat brain comigrates with authentic angiotensin II in high pressure liquid chromatography. Circ Res 1985; 56:212-219.
38. Kim S, Hosoi M, Shimamoto K, Takada T, Yamamoto K. Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertension. Biochem Biophys Res Commun 1991; 178:151-157.
39. Andrade MC, Quinto BM, Carmona AK, Ribas OS, Boim MA, Schor N, Casarini DE. Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture. J Hypertens 1998; 16:2063-2074.